Details

Product number
6228302
CPT
-
Packaging group
4 x 1477
Unit
ml
Composition
I) Glucoselösung 42 %: glucosum 187 g ut glucosum monohydricum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 446 ml. II) Aminosäurenlösung: alaninum 10.5 g, argininum 9 g, glycinum 8.2 g, histidinum 2.2 g, isoleucinum 3.8 g, leucinum 5.6 g, lysinum anhydricum 5 g ut lysini acetas, methioninum 3.2 g, phenylalaninum 3.8 g, prolinum 8.4 g, serinum 4.9 g, taurinum 0.75 g, threoninum 3.3 g, tryptophanum 1.5 g, tyrosinum 0.3 g, valinum 4.6 g, acidum aceticum glaciale, aqua ad iniectabile ad solutionem pro 750 ml. III) Fettemulsion: sojae oleum raffinatum 16.9 g, triglycerida media 16.9 g, olivae oleum raffinatum 14.1 g, piscis oleum 8.4 g, int-rac-alpha-tocopherolum, phospholipida ex ovo purificata, glycerolum, natrii oleas, natrii hydroxidum, aqua ad iniectabile ad emulsionem pro 281 ml. I) et II) et III) corresp.: aminoacida 75 g, nitrogenia 12 g, carbohydrata 188 g, materia crassa 56 g, in emulsione recenter mixta 1477 ml. Corresp. 6700 kJ pro 1477 ml corresp. natrium 9.58 mg.

Articles (1)

SmofKabiven EF, Infusionsemulsion 1477 ml
Infusionsemulsion
4 x 1477
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
24/08/2026
Professional SmPC
Français
24/08/2026
Professional SmPC
Italien
24/08/2026

Detailed composition

Substance Quantity Type Category
glucosum
187.0 G Substance Wirkstoff (Principe actif)
aminoacida
75.0 G Substance Wirkstoff (Principe actif)
alaninum
10.5 G Substance Wirkstoff (Principe actif)
sojae oleum raffinatum
16.9 G Substance Wirkstoff (Principe actif)
argininum
9.0 G Substance Wirkstoff (Principe actif)
glucosum monohydricum
- Substance WIZUS
nitrogenia
12.0 G Substance Wirkstoff (Principe actif)
triglycerida media
16.9 G Substance Wirkstoff (Principe actif)
acidum hydrochloridum
- Substance HNIDK
olivae oleum raffinatum
14.1 G Substance Wirkstoff (Principe actif)
glycinum
8.2 G Substance Wirkstoff (Principe actif)
carbohydrata
188.0 G Substance Wirkstoff (Principe actif)
materia crassa
56.0 G Substance Wirkstoff (Principe actif)
histidinum
2.2 G Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
piscis oleum
8.4 G Substance Wirkstoff (Principe actif)
int-rac-alpha-tocopherolum
- Substance HNIDK
isoleucinum
3.8 G Substance Wirkstoff (Principe actif)
phospholipida ex ovo purificata
- Substance HNIDK
leucinum
5.6 G Substance Wirkstoff (Principe actif)
glycerolum
- Substance HNIDK
lysinum anhydricum
5.0 G Substance Wirkstoff (Principe actif)
natrii oleas
- Substance HNIDK
natrium
9.58 MG Substance HBESI
lysini acetas
- Substance WIZUS
natrii hydroxidum
- Substance HNIDK
methioninum
3.2 G Substance Wirkstoff (Principe actif)
phenylalaninum
3.8 G Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
prolinum
8.4 G Substance Wirkstoff (Principe actif)
serinum
4.9 G Substance Wirkstoff (Principe actif)
taurinum
0.75 G Substance Wirkstoff (Principe actif)
threoninum
3.3 G Substance Wirkstoff (Principe actif)
tryptophanum
1.5 G Substance Wirkstoff (Principe actif)
tyrosinum
0.3 G Substance Wirkstoff (Principe actif)
valinum
4.6 G Substance Wirkstoff (Principe actif)
acidum aceticum glaciale
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
62283
Drug name
SmofKabiven EF, Infusionsemulsion
Galenic form
EMUI
ATC Code
B05BA10
Authorization status
Z
Dispensation category
B
First authorization
10/08/2012
Authorization expiration date
31/12/9999
IT number
07.01.2.
Domain
Human medicine
Field of application
Parenterale Ernährung für Erwachsene

Packaging details

Description (FR)
SMOFKABIVEN EF émuls perf 1477ml 4 pce
Description (DE)
SMOFKABIVEN EF Inf Emuls 1477ml 4 Stk
Market launch
10/08/2012
Narcotic (BTM)
No

Other packaging sizes

SMOFKABIVEN EF émuls perf 986ml 4 pce
4 x 986 ML
View
Buy us a coffee Explore the data